blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0892809

EP0892809 - FHIT PROTEINS AND NUCLEIC ACIDS AND METHODS BASED THEREON [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.03.2007
Database last updated on 13.11.2024
Most recent event   Tooltip01.01.2010Lapse of the patent in a contracting state
New state(s): LU		published on 03.02.2010  [2010/05]
Applicant(s)For all designated states
THOMAS JEFFERSON UNIVERSITY
1020 Walnut Avenue Philadelphia
Pennsylvania 19107 / US
[2006/21]
Former [1999/04]For all designated states
THOMAS JEFFERSON UNIVERSITY
11th and Walnut Streets
Philadelphia Pennsylvania 19107 / US
Inventor(s)01 / CROCE, Carlo, M.
1829 Delancey Street
Philadelphia, PA 19103 / US
02 / HUEBNER, Frances, K.
1829 Delancey Street
Philadelphia, PA 19103 / US
[1999/04]
Representative(s)Silveston, Judith, et al
ABEL & IMRAY
20 Red Lion Street
London, WC1R 4PQ / GB
[N/P]
Former [1999/04]Silveston, Judith, et al
ABEL & IMRAY Northumberland House 303-306 High Holborn
London, WC1V 7LH / GB
Application number, filing date97905817.907.02.1997
[1999/04]
WO1997US01937
Priority number, dateUS1996059887309.02.1996         Original published format: US 598873
US1996060543022.02.1996         Original published format: US 605430
[1999/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9729119
Date:14.08.1997
Language:EN
[1997/35]
Type: A1 Application with search report 
No.:EP0892809
Date:27.01.1999
Language:EN
The application published by WIPO in one of the EPO official languages on 14.08.1997 takes the place of the publication of the European patent application.
[1999/04]
Type: B1 Patent specification 
No.:EP0892809
Date:24.05.2006
Language:EN
[2006/21]
Search report(s)International search report - published on:US14.08.1997
(Supplementary) European search report - dispatched on:EP27.08.2002
ClassificationIPC:C12N15/11, C12N15/62, C12N5/10, C07K16/40, C07K1/00, C07H21/04, C12Q1/68, A61K38/46, A01K67/027, A61K39/00, G01N33/573
[2002/24]
CPC:
C07K14/4703 (EP,US); A61P1/00 (EP); A61P11/00 (EP);
A61P13/00 (EP); A61P13/12 (EP); A61P15/00 (EP);
A61P19/00 (EP); A61P35/00 (EP); C07K16/18 (EP,US);
A61K38/00 (EP,US); C07K2319/00 (EP,US) (-)
Former IPC [1999/04]C07K1/00, C07H21/04, A61K39/00
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1999/04]
TitleGerman:FHIT PROTEINE UND NUKLEINSÄUREN SOWIE DARAUF BASIERENDE VERFAHREN[2005/43]
English:FHIT PROTEINS AND NUCLEIC ACIDS AND METHODS BASED THEREON[1999/04]
French:PROTEINES ET ACIDES NUCLEIQUES FHIT ET PROCEDES AFFERENTS[1999/04]
Former [1999/04]FHIT PROTEINE UND NUKLEINSÄURENSOWIE DARAUF BASIERENDE VERFAHREN
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase08.09.1998National basic fee paid 
08.09.1998Search fee paid 
08.09.1998Designation fee(s) paid 
08.09.1998Examination fee paid 
Examination procedure03.09.1997Request for preliminary examination filed
International Preliminary Examining Authority: US
08.09.1998Examination requested  [1999/04]
09.07.2003Despatch of a communication from the examining division (Time limit: M06)
19.01.2004Reply to a communication from the examining division
03.02.2005Despatch of a communication from the examining division (Time limit: M06)
05.08.2005Reply to a communication from the examining division
05.10.2005Despatch of a communication from the examining division (Time limit: M01)
10.11.2005Reply to a communication from the examining division
30.11.2005Communication of intention to grant the patent
23.03.2006Fee for grant paid
23.03.2006Fee for publishing/printing paid
Divisional application(s)EP06010581.4  / EP1795203
Opposition(s)27.02.2007No opposition filed within time limit [2007/18]
Fees paidRenewal fee
10.02.1999Renewal fee patent year 03
11.02.2000Renewal fee patent year 04
15.02.2001Renewal fee patent year 05
13.02.2002Renewal fee patent year 06
12.02.2003Renewal fee patent year 07
26.02.2004Renewal fee patent year 08
04.02.2005Renewal fee patent year 09
27.02.2006Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT24.05.2006
BE24.05.2006
CH24.05.2006
FI24.05.2006
IT24.05.2006
LI24.05.2006
NL24.05.2006
DK24.08.2006
SE24.08.2006
GR25.08.2006
ES04.09.2006
PT24.10.2006
IE07.02.2007
LU07.02.2007
[2010/05]
Former [2008/21]AT24.05.2006
BE24.05.2006
CH24.05.2006
FI24.05.2006
IT24.05.2006
LI24.05.2006
NL24.05.2006
DK24.08.2006
SE24.08.2006
GR25.08.2006
ES04.09.2006
PT24.10.2006
IE07.02.2007
Former [2008/12]AT24.05.2006
BE24.05.2006
CH24.05.2006
FI24.05.2006
IT24.05.2006
LI24.05.2006
NL24.05.2006
DK24.08.2006
SE24.08.2006
ES04.09.2006
PT24.10.2006
IE07.02.2007
Former [2008/07]AT24.05.2006
BE24.05.2006
CH24.05.2006
FI24.05.2006
IT24.05.2006
LI24.05.2006
NL24.05.2006
DK24.08.2006
SE24.08.2006
ES04.09.2006
PT24.10.2006
Former [2007/21]AT24.05.2006
BE24.05.2006
CH24.05.2006
FI24.05.2006
LI24.05.2006
NL24.05.2006
DK24.08.2006
SE24.08.2006
ES04.09.2006
PT24.10.2006
Former [2007/17]AT24.05.2006
BE24.05.2006
CH24.05.2006
FI24.05.2006
LI24.05.2006
DK24.08.2006
SE24.08.2006
ES04.09.2006
PT24.10.2006
Former [2007/03]AT24.05.2006
CH24.05.2006
FI24.05.2006
LI24.05.2006
SE24.08.2006
ES04.09.2006
Former [2007/01]AT24.05.2006
FI24.05.2006
SE24.08.2006
ES04.09.2006
Former [2006/50]SE24.08.2006
ES04.09.2006
Former [2006/49]SE24.08.2006
Documents cited:Search[YA]EP0500290  (UNIV CALIFORNIA [US]) [Y] 25-27 * page 4, line 10 - line 17; table 1 * * page 25, line 16 - line 36 * * page 27, line 21 - line 55; figures 4-9 * [A] 69-79,82;
 [YA]US5330892  (VOGELSTEIN BERT [US], et al) [Y] 66,68,95,96 * figure 1; examples 1-3 * * column 13, line 17 - line 42 * [A] 1-40,69-79,82,100-113;
 [A]US5352775  (ALBERTSEN HANS [US], et al) [A] 1-40,69-79,82,100-113 * column 5, line 23 - line 26 * * figure 1; example 1 * * example 14 * * example 15 *;
 [PX]  - OHTA MASATAKA ET AL, "The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers.", CELL, (19960223), vol. 84, no. 4, ISSN 0092-8674, pages 587 - 597, XP002194943 [PX] 1-99,110-113 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0092-8674(00)81034-X
 [PX]  - SOZZI GABRIELLA ET AL, "The FHIT gene at 3p14.2 is abnormal in lung cancer.", CELL, (19960405), vol. 85, no. 1, ISSN 0092-8674, pages 17 - 26, XP002194944 [PX] 100-109 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0092-8674(00)81078-8
 [PX]  - BARNES LARRY D ET AL, "Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"-P-1,P-3-triphosphate hydrolase.", BIOCHEMISTRY, (19960910), vol. 35, no. 36, ISSN 0006-2960, pages 11529 - 11535, XP002194945 [PX] 1-113 * the whole document *

DOI:   http://dx.doi.org/10.1021/bi961415t
 [XDY]  - HILLIER L. ET AL., "The WashU-Merck EST Project", EMBL, (19950421), XP002194947 [XD] 29,65 * abstract * [Y] 66,68,95,96
 [XY]  - HILLIER L. ET AL., "The WashU-Merck EST Project", EMBL, (19950405), XP002194948 [X] 29,65 * abstract * [Y] 66,68,95,96
 [XDY]  - HILLIER L. ET AL., "The WashU-Merck EST Project", EMBL, (19950421), XP002194949 [XD] 29,65 * abstract * [Y] 66,68,95,96
 [YD]  - MICHAELIS SUSANNE C ET AL, "Characterization and chromosomal assignment of yeast artificial chromosomes containing human 3p13-p21-specific sequence tagged sites.", CANCER GENETICS AND CYTOGENETICS, (1995), vol. 81, no. 1, ISSN 0165-4608, pages 1 - 12, XP002195556 [YD] 25-27 * figure 1 *

DOI:   http://dx.doi.org/10.1016/0165-4608(94)00208-8
 [T]  - INGVARSSON SIGURDUR, "FHIT alterations in breast cancer.", SEMINARS IN CANCER BIOLOGY, (200110), vol. 11, no. 5, ISSN 1044-579X, pages 361 - 366, XP002194946 [T] 1-113 * the whole document *

DOI:   http://dx.doi.org/10.1006/scbi.2001.0391
 [T]  - KISSELEV L L ET AL, "Diadenosine oligophosphates (ApnA), a novel class of signalling molecules?", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (19980508), vol. 427, no. 2, ISSN 0014-5793, pages 157 - 163, XP004257852 [T] 1-113 * page 161, column 1, paragraph 3 - page 162, column 1, paragraph 1; figure 2 *

DOI:   http://dx.doi.org/10.1016/S0014-5793(98)00420-7
International search[AP]  - CELL, 23 February 1996, Vol. 84, No. 4, OHTA et al., "The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma-Associated(3;8)Breakpoint, is Abnormal in Digestive Tract Cancers", pages 587-597.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.